![Simon John Peat](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Simon John Peat
Oprichter bij Project Better Energy Ltd.
Oorsprong van het eerstegraads netwerk van Simon John Peat
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Se Group Ltd.
![]() Se Group Ltd. Miscellaneous Commercial ServicesCommercial Services SE Group Ltd. is a British company that provides professional, scientific, and technical services. The private company was founded in 2013 and is based in Brighouse, UK.
7
| Private Company | Miscellaneous Commercial Services | 7 |
Project Better Energy Ltd.
![]() Project Better Energy Ltd. Electric UtilitiesUtilities Project Better Energy Ltd. is a British company that generates electric power. The private company is based in Burton-on-Trent, UK. and has subsidiaries in United Kingdom. Project Better Energy was founded in 2012.
2
| Holding Company | Electric Utilities | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Simon John Peat via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
GRESHAM TECHNOLOGIES PLC | Packaged Software | President | |
Biosceptre (Aust) Pty Ltd.
![]() Biosceptre (Aust) Pty Ltd. Pharmaceuticals: MajorHealth Technology Biosceptre (Aust) Pty Ltd. develops and commercializes antibody technologies for applications in the diagnosis and treatment of cancer. The company was founded in 2000 and is headquartered in North Ryde, Australia. | Pharmaceuticals: Major | Chairman | |
Biosceptre International Ltd.
![]() Biosceptre International Ltd. BiotechnologyHealth Technology Part of Biosceptre (Aust) Pty Ltd., Biosceptre International Ltd. is a biopharmaceutical company based in Babraham, UK. The British company is focused on developing their BRiDGECAR™ system, which combines nfP2X7-targeted technology with highly potent chimeric antigen receptor (CAR) T-cell therapy and multiple targeted antibodies. The company's researchers are pioneers in cancer therapeutic development, with a vision of targeted treatment for millions of cancer patients across the world. The company's multi-targeted BRiDGECAR™ system has the potential to benefit a range of malignancies and make a drastic difference to the lives of millions of cancer patients. The company's advisory board includes Sir Gregory Winter, a 2018 Nobel Prize winner in Chemistry. | Biotechnology | Chairman |
Statistieken
Internationaal
Verenigd Koninkrijk | 3 |
Australië | 2 |
Sectoraal
Health Technology | 3 |
Technology Services | 2 |
Operationeel
Director/Board Member | 10 |
Chairman | 2 |
President | 1 |
Sterkste connecties
- Beurs
- Insiders
- Simon John Peat
- Bedrijfsconnecties